| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695382 | Gynecologic Oncology | 2017 | 8 Pages |
Abstract
MMR testing that includes MLH1 methylation analysis defines a subset of tumors that have worse prognostic features and reduced RFS.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Casey M. Cosgrove, David E. Cohn, Heather Hampel, Wendy L. Frankel, Dan Jones, Joseph P. McElroy, Adrian A. Suarez, Weiqiang Zhao, Wei Chen, Ritu Salani, Larry J. Copeland, David M. O'Malley, Jeffrey M. Fowler, Ahmet Yilmaz, Alexis S. Chassen,